Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans

Ruth P Duecker1, Ines De Mir Messa2, Silvija-Pera Jerkic1

  • 1Division for Allergy, Pneumology and Cystic Fibrosis Department for Children and Adolescence Goethe University Frankfurt Germany.

Abstract

Insights

Post-infectious bronchiolitis obliterans (PiBO) involves airway inflammation. This study identified specific microRNAs (miRNAs) linked to PiBO, suggesting their potential as diagnostic biomarkers and therapeutic targets.

Area of Science:

  • Pulmonary Medicine
  • Epigenetics
  • Molecular Biology

Background:

  • Post-infectious bronchiolitis obliterans (PiBO) is a rare, chronic airway disease following severe infection.
  • MicroRNAs (miRNAs) are epigenetic regulators implicated in controlling inflammation and disease progression.

Purpose of the Study:

  • To identify biomarkers at the post-transcriptional gene regulation level for characterizing PiBO.
  • To investigate the role of miRNAs in the pathogenesis of PiBO.

Main Methods:

  • Next-generation sequencing (NGS) was used to analyze miRNA expression in 39 PiBO patients and 31 controls.
  • Pathway enrichment and protein-protein interaction network analyses were performed to evaluate miRNA targets.
  • Quantitative reverse transcription PCR (qRT-PCR) validated specific miRNA dysregulations.

Main Results:

  • PiBO patients exhibited reduced lung function and increased airway inflammation markers (neutrophils, IL-1β, IL-6, IL-8, TGF-β).
  • NGS identified 22 significantly dysregulated miRNAs (17 upregulated, 5 downregulated) in PiBO patients.
  • Four miRNAs (miR-335-5p, miR-186-5p, miR-30b-5p, miR-30c-5p) correlated with lung function (FEV1) and were involved in key signaling pathways.

Conclusions:

  • Aberrant miRNA expression profiles are characteristic of PiBO, affecting inflammation and fibrosis pathways.
  • The identified miRNAs serve as potential biomarkers for PiBO diagnosis.
  • These miRNAs represent promising targets for future miRNA-based therapeutics in PiBO.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
680
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
9.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
793
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.0K